The progressive fibrosing interstitial lung disease market is anticipated to increase due to factors such as increased awareness of PF-ILD along with the expected launch of emerging therapies
The overall liver fibrosis market size is anticipated to increase owing to the rising prevalent cases. In addition, due to the lack of approved drugs, the expected launch of emerging therapy
The rapid spread of influenza virus worldwide is driving the demand for the development of efficient influenza vaccine. Increasing clinical trials for new product development by market players
The genital warts market size is expected to grow with the anticipated launch of emerging therapies in 7MM and China during the forecast period. LAS VEGAS, Aug. 30, 2022 /PRNewswire/
Major depressive disorder pipeline constitutes 60+ key companies continuously working towards developing 75+ major depressive disorder treatment therapies, analyzes DelveInsight LAS VEGAS